| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.09 | 0.05 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.056 | 0.05 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.07 | 0.05 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.26 | 0.05 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.05 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.13 | 0.05 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.062 | 0.05 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.05 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.05 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.092 | 0.05 |